Bridgeway Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-107,700
| Closed | -$274K | – | 1473 |
|
|
2023
Q1 | $274K | Sell |
107,700
-115,000
| -52% | -$292K | 0.01% | 1040 |
|
|
2022
Q4 | $416K | Buy |
222,700
+100,000
| +81% | +$187K | 0.01% | 925 |
|
|
2022
Q3 | $315K | Hold |
122,700
| – | – | 0.01% | 1021 |
|
|
2022
Q2 | $237K | Hold |
122,700
| – | – | 0.01% | 1053 |
|
|
2022
Q1 | $364K | Sell |
122,700
-35,000
| -22% | -$104K | 0.01% | 1018 |
|
|
2021
Q4 | $708K | Buy |
+157,700
| New | +$708K | 0.01% | 878 |
|
|
2020
Q2 | – | Sell |
-151,800
| Closed | -$478K | – | 1420 |
|
|
2020
Q1 | $478K | Buy |
151,800
+50,000
| +49% | +$157K | 0.01% | 778 |
|
|
2019
Q4 | $410K | Buy |
101,800
+6,800
| +7% | +$27.4K | 0.01% | 1054 |
|
|
2019
Q3 | $410K | Hold |
95,000
| – | – | 0.01% | 1025 |
|
|
2019
Q2 | $379K | Buy |
+95,000
| New | +$379K | ﹤0.01% | 1045 |
|
|
2014
Q4 | – | Sell |
-5,583
| Closed | -$136K | – | 1528 |
|
|
2014
Q3 | $136K | Sell |
5,583
-5,834
| -51% | -$142K | ﹤0.01% | 1386 |
|
|
2014
Q2 | $273K | Hold |
11,417
| – | – | 0.01% | 1273 |
|
|
2014
Q1 | $422K | Buy |
11,417
+5,834
| +104% | +$216K | 0.01% | 1149 |
|
|
2013
Q4 | $225K | Hold |
5,583
| – | – | 0.01% | 1283 |
|
|
2013
Q3 | $213K | Buy |
+5,583
| New | +$213K | 0.01% | 1301 |
|